Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimal flexible designs in phase II clinical trials

T T Chen1, T H Ng

  • 1Biometric Research Branch, National Cancer Institute, Bethesda, Maryland 20892, USA. tchen@helix.nih.gov

Statistics in Medicine
|November 20, 1998
PubMed
Summary

This study introduces flexible two-stage designs for phase II cancer trials, applying Simon

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Microsatellite status and minimal microsatellite shift in atypical endometrial hyperplasia and endometrial cancer: an analysis of 848 cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2026
Same author

[Construction of etiological diagnosis model for pathogen-negative pulmonary tuberculosis using tuberculosis scores of GBP5, DUSP3, and TBP genes combined with inflammatory factors].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025
Same author

Correction: TRAF2 is a biologically important necroptosis suppressor.

Cell death and differentiation·2025
Same author

[Primary ovarian mesonephric-like adenocarcinoma: a clinicopathological analysis of 17 cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2025
Same author

Nimodipine ameliorates cognitive dysfunction and neurological injury after subarachnoid hemorrhage in rats by upregulating microRNA-31-5p targeting hypoxia-inducible factor 1 subunit alpha inhibitor.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2025
Same author

[Small cell carcinoma of the ovary of hypercalcaemic type: a clinicopathological analysis of sixteen cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2024

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Cancer Research

Background:

  • Phase II cancer clinical trials commonly use two-stage designs to assess drug efficacy.
  • Simon's optimal and minimax criteria are established benchmarks for these designs.
  • Practical challenges in cooperative group settings can hinder exact sample size adherence.

Purpose of the Study:

  • To define and evaluate flexible two-stage designs for phase II cancer trials.
  • To apply Simon's optimal and minimax criteria to these flexible designs.
  • To minimize the number of patients exposed to ineffective drugs.

Main Methods:

  • Explicitly defined flexible designs as collections of two-stage designs with variable first and second stage sizes.
  • Applied Simon's optimal and minimax criteria to assess these flexible designs.
  • Focused on minimizing the number of patients tested on ineffective treatments.

Main Results:

  • Flexible designs offer adaptability in sample size within defined ranges.
  • Application of Simon's criteria to flexible designs aims to optimize patient allocation.
  • The proposed approach seeks to enhance efficiency in early-phase cancer drug evaluation.

Conclusions:

  • Flexible two-stage designs provide a practical approach to phase II cancer trials.
  • Utilizing Simon's criteria with flexible designs can improve resource allocation.
  • This methodology aids in efficiently identifying promising cancer therapies.

Related Experiment Videos